Vanda Pharmaceuticals INC.
At a glance
Employees100-499
In business since2015
HeadquartersWashington, DC
US patents105
SAM.gov UEING5JU1TQ3379
CAGE code68U09
Incorporated inDE
LEI529900AY8VOOQBKJ0O70
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
105 US patents granted 2010–2025, 50 of them in the five years to SEP 2025.
Pharmaceuticals 87Organic fine chemistry 13Medical technology 3Biotechnology 1
- Method of improving sleepUS 12,427,132 · granted SEP 30, 2025
- Methods of treating multiple sclerosisUS 12,419,869 · granted SEP 23, 2025
- Pharmaceutical combination comprising a selective S1P1 receptor agonistUS 12,409,167 · granted SEP 9, 2025
- Method for improving or enhancing cognitionUS 12,403,134 · granted SEP 2, 2025
- Methods of treating multiple sclerosisUS 12,357,616 · granted JUL 15, 2025
Newest 5 shown · Granted to Vanda Pharmaceuticals INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Vanda Pharmaceuticals INC. | Washington | DC | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.